Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. TENB
9. SPCX
10. TLT

Go back to Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.20 +0.20 (0.19%)
Previous Close $107.00    52 Week High $18.39 
Open $107.96    52 Week Low $6.96 
Day High $108.23    P/E N/A 
Day Low $106.34    EPS $-0.58 
Volume 861,791